PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.87
ESG score 90-95% of BTAI's 61.39. Bill Ackman would demand clear ESG improvement catalysts.
52.42
Environmental score 90-95% of BTAI's 57.93. Bill Ackman would demand clear environmental improvement catalysts.
57.59
Social score 80-90% of BTAI's 64.18. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
57.61
Governance score 90-95% of BTAI's 62.07. Bill Ackman would demand clear governance improvement catalysts.